tradingkey.logo

Check Cap Ltd

CHEK
查看详细走势图
1.610USD
0.000
收盘 12/19, 16:00美东报价延迟15分钟
9.42M总市值
亏损市盈率 TTM

Check Cap Ltd

1.610
0.000
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

0.00%

5天

0.00%

1月

+19.26%

6月

+118.01%

今年开始到现在

+62.64%

1年

+172.88%

查看详细走势图

TradingKey Check Cap Ltd股票评分

单位: USD 更新时间: 2025-10-27

操作建议

当前估值合理,机构持股占比非常高,目前股价在压力位和支撑位之间,可以做区间波段操作。

Check Cap Ltd评分

相关信息

行业排名
298 / 501
全市场排名
559 / 4682
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 0 位分析师
--
评级
0.000
目标均价
0.00%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Check Cap Ltd亮点

亮点风险
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
利润高增长
公司净利润处于行业前列,最新年度总收入0.00美元
估值高估
公司最新PE估值-0.37,处于3年历史高位
机构减仓
最新机构持股129.83K股,环比减少29.02%
活跃度增加
近期活跃度增加,过去20天平均换手率1.12

Check Cap Ltd新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Check Cap Ltd简介

Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
公司代码CHEK
公司Check Cap Ltd
CEOOvadia (Alex)
网址https://check-cap.com/

常见问题

Check Cap Ltd(CHEK)的当前股价是多少?

Check Cap Ltd(CHEK)的当前股价是 1.610。

Check Cap Ltd的股票代码是什么?

Check Cap Ltd的股票代码是CHEK。

Check Cap Ltd股票的52周最高点是多少?

Check Cap Ltd股票的52周最高点是3.130。

Check Cap Ltd股票的52周最低点是多少?

Check Cap Ltd股票的52周最低点是0.560。

Check Cap Ltd的市值是多少?

Check Cap Ltd的市值是9.42M。

Check Cap Ltd的净利润是多少?

Check Cap Ltd的净利润为-25.15M。

现在Check Cap Ltd(CHEK)的股票是买入、持有还是卖出?

根据分析师评级,Check Cap Ltd(CHEK)的总体评级为--,目标价格为--。

Check Cap Ltd(CHEK)股票的每股收益(EPS TTM)是多少

Check Cap Ltd(CHEK)股票的每股收益(EPS TTM)是-4.300。
KeyAI